Clinical Trial Update: Flavopiridol Plus Radiation Therapy Followed By Gemcitabine Hydrochloride in Treating Patients With Locally Advanced, Unresectable Pancreatic Cancer [Phase 1]

View source ↗

Summary

A phase 1 trial evaluating flavopiridol with radiation therapy followed by gemcitabine hydrochloride in locally advanced, unresectable pancreatic cancer has com…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Flavopiridol (alvocidib)
• Gemcitabine HCl (gemcitabine)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Adenocarcinoma of the Pancreas, Recurrent Pancreatic Cancer | Phase 1 | Status: COMPLETED